ExploreWatchlistsPricing
  1. JP-listed companies
  2. KANEKA CORPORATION
  3. Financials
  4. Marketable securities, current

KANEKA CORPORATION (4118)

Market cap
¥332.8B
P/E ratio
9.9x
Kaneka develops advanced materials, medical devices, solar technology, and nutrition products across four business units serving infrastructure, housing, healthcare, and food industries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndMarketable securities, current (Million JPY)YoY (%)
Mar 31, 202394-56.68%
Mar 31, 2022217+5.85%
Mar 31, 2021205+7.89%
Mar 31, 2020190-18.10%
Mar 31, 2019232+110.91%
Mar 31, 2018110+0.00%
Mar 31, 2017110+0.00%
Mar 31, 2016110+0.00%
Mar 31, 2015110

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat